Dashboard
Faculty
Programme
Login
Dashboard
Faculty
Programme
Login
Novartis: Optimizing long-term outcomes in kidney transplantation: innovative predictive tools and treatment pathways
Tuesday September 15, 2020 from 06:00 to 07:00
Room: Channel 1
IN-5.2 New immunosuppressive pathways in transplant therapy
Log in to add to favorites
Add Personal Notes
James S. Rush, Switzerland
New Product Director Early Pipeline
Immunology, Hepatology and Dermatology
Novartis Pharma AG
Presentations by James S. Rush
Tue-15 from 06:00 - 07:00 in room Channel 1
Novartis: Optimizing long-term outcomes in kidney transplantation: innovative predictive tools and treatment pathways
New immunosuppressive pathways in transplant therapy
Email:
info@virtual.tts.org
+1.514.874-1717
© 2024 TTS 2020
